Figure 5.
![Event-free survival plots for 2-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/6/12/10.1182_bloodadvances.2021006351/3/advancesadv2021006351f5.png?Expires=1735828799&Signature=gSounPlqd1hjP23ePhoaGD-Sc4LzYr~IqFJ9psJdYZTjDThWsjgGn8QIuODr5HvwDe~4jXOqQpg~AAOAKt7-J20R2jlcSZbF~l4KwMjaGY~ysQ5GC9cA10u5sznSrCmYd6KftIzHxv4cVzUugu9ph93oNOoEUTwfaxQkoGm6-1Json26btMOB1P2qaNp95RUkISU5HCP9hiBPUtLgbFihU2BltM1vIgMttUot-c6Addtqv9vFUFFSvKKo4BVbzyh2rz6Ip63LfgHvA3pslMo-Q~U8gD0OHFwSl9FktIs~ghz0u1tMqtYfp~Ems3MO9heylcmuOv2B0RytmoPTmMuvw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Event-free survival plots for 2-year outlook on the full cohort. Patients were stratified by the classifier using CLL-IPI variables (TP53 aberrations, IGHV mutational status, B2M level, clinical stage, and age [IPI]) (A,C,E,G) and addition of (para)clinical variables to the CLL-IPI variables (+BL) (B,D,F,H). Overall survival (A-B), treatment-free survival (C-D), treatment and infection–free survival (E-F), and infection-free survival (G-H). HR, hazard ratio.